Miller PD, Pannacciulli N, Brown JP, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016, 101(8):3163-3170. doi: 10.1210/jc.2016-1801.
Advertisement
Articles by Miller PD, Pannacciulli N, Brown JP, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016, 101(8):3163-3170. doi: 10.1210/jc.2016-1801.
Advertisement
Latest Updated Articles
- Study Summary: Switching From Oral Bisphosphonates to Denosumab or Zoledronic Acid in Women With Postmenopausal Osteoporosis
Published: July 24th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Measles Outbreaks Cause Financial, Public Health Burden in US
4
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
5
